Co-morbidity and pain sites in long-term gynecological cancer survivors and women in the general population

► No differences in co-morbidity or number of pain sites between long-term gynecological cancer survivors and women from the general population ► After adjustment for socioeconomic conditions, musculoskeletal disorders are the strongest predictor of number of pain sites.